Profile
Karl Peggs was the founder of Achilles Therapeutics UK Ltd., founded in 2016, where the title held was Director & Chief Medical Officer in 2020.
Dr. Peggs was the founder of Achilles Therapeutics Plc, founded in 2020, where the title held was Chief Medical Officer from 2020 to 2021.
Dr. Peggs currently holds the position of Scientific Director-NIHR Blood at University College London Hospitals NHS Foundation Trust.
Dr. Peggs is a Member at The Royal Society of Medicine.
Dr. Peggs is a Professor at UCL Cancer Institute Research Trust.
Dr. Peggs completed undergraduate education at Oxford University Medical School and graduate education at the University of Cambridge.
Karl Peggs active positions
| Companies | Position | Start |
|---|---|---|
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services Provide medical courses for continuing professional development | Corporate Officer/Principal | - |
UCL Cancer Institute Research Trust | Corporate Officer/Principal | - |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Corporate Officer/Principal | - |
Former positions of Karl Peggs
| Companies | Position | End |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Founder | 01/03/2021 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Founder | 22/12/2020 |
Training of Karl Peggs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services Provide medical courses for continuing professional development | Commercial Services |
UCL Cancer Institute Research Trust | |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Oxford University Medical School
Oxford University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Karl Peggs
















